1. Home
  2. COCP vs CENN Comparison

COCP vs CENN Comparison

Compare COCP & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • CENN
  • Stock Information
  • Founded
  • COCP 2006
  • CENN 2013
  • Country
  • COCP United States
  • CENN United States
  • Employees
  • COCP N/A
  • CENN N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • CENN Auto Manufacturing
  • Sector
  • COCP Health Care
  • CENN Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • CENN Nasdaq
  • Market Cap
  • COCP 15.4M
  • CENN 13.8M
  • IPO Year
  • COCP N/A
  • CENN N/A
  • Fundamental
  • Price
  • COCP $1.00
  • CENN $0.17
  • Analyst Decision
  • COCP Strong Buy
  • CENN
  • Analyst Count
  • COCP 1
  • CENN 0
  • Target Price
  • COCP $6.00
  • CENN N/A
  • AVG Volume (30 Days)
  • COCP 82.9K
  • CENN 3.8M
  • Earning Date
  • COCP 11-14-2025
  • CENN 11-12-2025
  • Dividend Yield
  • COCP N/A
  • CENN N/A
  • EPS Growth
  • COCP N/A
  • CENN N/A
  • EPS
  • COCP N/A
  • CENN N/A
  • Revenue
  • COCP N/A
  • CENN $18,529,541.00
  • Revenue This Year
  • COCP N/A
  • CENN N/A
  • Revenue Next Year
  • COCP N/A
  • CENN N/A
  • P/E Ratio
  • COCP N/A
  • CENN N/A
  • Revenue Growth
  • COCP N/A
  • CENN N/A
  • 52 Week Low
  • COCP $0.90
  • CENN $0.13
  • 52 Week High
  • COCP $3.26
  • CENN $1.33
  • Technical
  • Relative Strength Index (RSI)
  • COCP 46.82
  • CENN 36.95
  • Support Level
  • COCP $0.90
  • CENN $0.13
  • Resistance Level
  • COCP $0.96
  • CENN $0.16
  • Average True Range (ATR)
  • COCP 0.05
  • CENN 0.02
  • MACD
  • COCP 0.00
  • CENN 0.01
  • Stochastic Oscillator
  • COCP 51.06
  • CENN 74.85

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: